A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis

International Journal of Rheumatic Diseases

Volumn 18, Issue 3, 2015, Pages 276-286

  Ali, Hassan ^a   Ng, Kiat R ^a   Low, Andrea H L ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Atherosclerosis; Coronary artery disease; Systematic review; Systemic sclerosis

Indexed keywords

ANGIOCARDIOGRAPHY; AUTOPSY; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY CONTROL; REVIEW; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; FEMALE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC;

CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 84928591089     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12566     Document Type: Review

References (38)

1. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66, 940-4.
2. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ (2003) Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 42, 292-7.
3. de Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M (2006) Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus 15, 675-82.
4. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH (2009) Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum 61, 1396-402.
5. Roman MJ, Shanker BA, Davis A et al. (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349, 2399-406.
6. Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57, 682-6.
7. Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37, 750-5.
8. Au K, Singh MK, Bodukam V et al. (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63, 2078-90.
9. Man A, Zhu Y, Zhang Y et al. (2013) The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72, 188-93.
10. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E (2008) Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 40, 180-96.
11. Szucs G, Timar O, Szekanecz Z et al. (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis-relevance for prevention of vascular complications. Rheumatology (Oxford) 46, 759-62.
12. Blagojevic J, Matucci Cerinic M (2007) Macrovascular involvement in systemic sclerosis: comorbidity or accelerated atherosclerosis? Curr Rheumatol Rep 9, 181-2.
13. Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59, 39-43.
14. Veale DJ, Collidge TA, Belch JJ (1995) Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 54, 853-5.
15. Sarwar A, Shaw LJ, Shapiro MD et al. (2009) Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2, 675-88.
16. Khurma V, Meyer C, Park GS et al. (2008) A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 59, 591-7.
17. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. [Cited 18 November 2013.] Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
18. D'Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46, 428-40.
19. Youssef P, Brama T, Englert H, Bertouch J (1995) Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 22, 469-72.
20. Mok MY, Lau CS, Chiu SS et al. (2011) Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis Rheum 63, 1387-95.
21. Nordin A, Jensen-Urstad K, Bjornadal L, Pettersson S, Larsson A, Svenungsson E (2013) Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther 15, R87.
22. Chu SY, Chen YJ, Liu CJ et al. (2013) Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 126, 982-8.
23. Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S (2012) Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 71, 1980-3.
24. Akram MR, Handler CE, Williams M et al. (2006) Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 45, 1395-8.
25. Tarek el G, Yasser AE, Gheita T (2006) Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol 25, 487-90.
26. Mok MY, Chiu SS, Lo Y et al. (2009) Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 38, 381-5.
27. Komocsi A, Pinter T, Faludi R et al. (2010) Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 69, 202-5.
28. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53, 483-90.
29. Dave AJ, Fiorentino D, Lingala B, Krishnan E, Chung L (2014) Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 66, 323-7.
30. Baraut J, Michel L, Verrecchia F, Farge D (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10, 65-73.
31. Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7, e33442.
32. Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA (2010) Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 39, 326-9.
33. Herrick AL, Illingworth KJ, Hollis S, Gomez-Zumaquero JM, Tinahones FJ (2001) Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology (Oxford) 40, 401-5.
34. Lopez LR, Simpson DF, Hurley BL, Matsuura E (2005) OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Ann N Y Acad Sci 1051, 313-22.
35. Sitia S, Tomasoni L, Atzeni F et al. (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9, 830-4.
36. Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe A, Guidi G (2006) Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 364, 345-8.
37. Bulkley BH, Klacsmann PG, Hutchins GM (1978) Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J 95, 563-9.
38. Derk CT, Jimenez SA (2007) Acute myocardial infarction in systemic sclerosis patients: a case series. Clin Rheumatol 26, 965-8.